Specialty Pharmacy

The risk of a solid subsequent malignant neoplasm is elevated in survivors of childhood Hodgkin lymphoma, according to an extended follow-up of more than 25 years.

Caplacizumab-yhdp (Cablivi, Sanofi) is a targeted treatment designed to inhibit the formation of blood clots in adults with acquired thrombotic thrombocytopenic purpura.

Data from 2 phase 3 trials showed significant improvement in disease activity in patients with moderate-to-severe atopic dermatitis treated with baricitinib (Olumiant).

Researchers at University of Texas Health Science Center at San Antonio studied 28,000 childhood cancer survivors to determine similarities in long-term effects for various chemotherapies.

Top news of the day across the health care landscape.

Injection drug use has been identified as a predominant risk factor for hepatitis C infection and the opioid epidemic has been suggested as a driver of a recent rise in infections.

Medicare Part D patients can face thousands of dollars in out-of-pocket costs for a single specialty tier drug.

Research seeks to uncover the mechanisms underlying the surging rate of Parkinson disease diagnoses.

Top news of the day across the health care landscape.

Blockchain, mobile health, and predictive analytics are just a few areas that could improve patient care and enhance the pharmacy industry.

Researchers have identified a link between CXCR4 expression, fibrosis, and immunosuppression in patients with metastatic breast cancer.

Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses the key role of specialty pharmacy in supporting patients and the health care team.

Top news of the day across the health care landscape.

A study of methotrexate in patients with psoriasis found that the immunosuppressive drug was more effective in patients without psoriatic arthritis than those with the added condition.

Scaling up prevention, treatment, and screening interventions can make substantial strides toward global hepatitis C elimination.

Top news of the day across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults.

The approval is based on data demonstrating improved progression-free survival and overall survival in patients with metastatic nonsquamous non-small cell lung cancer.

Most state pharmacy regulations do not specifically require verification of the prescriber’s license prior to dispensing.

Study evaluates whether patients with head and neck cancer who have PIK3A gene mutations could benefit from regular aspirin use.

Top news of the day across the health care landscape.

Topical medical grade cannabis ointment found to be safe and tolerable in early trial for skin disease.

An FDA-approved genetically modified herpes virus can effectively treat metastatic melanoma when injected into the tumor.

Top news of the day across the health care landscape.

A targeted therapeutic approach shrank tumors caused by medulloblastoma, a deadly form a pediatric brain cancer.

The generic drug (Wixela Inhub, Mylan) is indicated to treat patients with asthma and chronic obstructive pulmonary disease, including bronchitis and emphysema.